2015
DOI: 10.1007/8904_2015_470
|View full text |Cite
|
Sign up to set email alerts
|

Pearson Syndrome: A Retrospective Cohort Study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica)

Abstract: Pearson syndrome (PS) is a very rare and often fatal multisystemic mitochondrial disorder involving the liver, kidney, pancreas, and hematopoietic and central nervous system. It is characterized principally by a transfusion-dependent anemia that usually improves over time, a tendency to develop severe infections, and a high mortality rate. We describe a group of 11 PS patients diagnosed in Italy in the period 1993-2014. The analysis of this reasonably sized cohort of patients contributes to the clinical profil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
44
0
5

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(53 citation statements)
references
References 17 publications
(15 reference statements)
4
44
0
5
Order By: Relevance
“…The prognosis of PS is poor. Eight of 11 children with PS in the study from Italy and 7 of 11 patients from the UK died due to sepsis or renal failure, similar to our patients with neonatal onset of PS. It may be of importance that these patients had neutropenia and the highest percentage of sideroblasts and ring sideroblasts.…”
Section: Discussionsupporting
confidence: 82%
“…The prognosis of PS is poor. Eight of 11 children with PS in the study from Italy and 7 of 11 patients from the UK died due to sepsis or renal failure, similar to our patients with neonatal onset of PS. It may be of importance that these patients had neutropenia and the highest percentage of sideroblasts and ring sideroblasts.…”
Section: Discussionsupporting
confidence: 82%
“…13 No parece existir relación entre el número de pares de bases afectados y la localización de estos en el genoma con el tipo de afectación clínica y la evolución. 8 No existe, actualmente, un tratamiento curativo y es frecuente el fallecimiento de estos pacientes (hasta un 50%) en los primeros 3 años de vida 7,11 a consecuencia de infecciones y complicaciones asociadas a las graves citopenias. 13 A partir de esta edad, el cuadro hematológico tiende a mejorar y la mortalidad se debe a otras complicaciones que presenta el síndrome de Pearson ( Tabla 2).…”
Section: Discussionunclassified
“…1 A recent study from Italy estimates incidence of PS as 1 in million births. 2 Patients present in infancy with transfusion dependent severe macrocytic anemia often associated with variable degrees of neutropenia, thrombocytopenia, metabolic acidosis and tissue dysfunction. 1,3 The early onset of severe anemia, variable penetrance and sporadic genetic inheritance make it difficult to differentiate PS from Diamond BLACKFAN Anemia (DBA).…”
Section: Introductionmentioning
confidence: 99%